Sinoway Industrial Co., Ltd.

Capecitabine 154361-50-9 Capecitabine 154361-50-9

Capecitabine 154361-50-9
Related Products
  • NanoActive alpha lipoic acid (ALA) 1077-28-7

    1.Basic information of NanoActive alpha lipoic acidProduct Name: NanoActive alpha lipoic acid (ALA)Other Names: NanoActive THIOOCTIC ACIDAppearance: yellow, viscous and transparent liquidTest Method: ...

  • NanoActive Astaxanthin 472-61-7

    1.Basic information of NanoActive AstaxanthinProduct Name: NanoActive AstaxanthinOther Names: NanoActive AstaAppearance: reddish to dark red, viscous and transparent liquidTest Method: HPLCCAS NO.: 47...

  • NanoActive Curcumin 458-37-7

    1.Basic information of NanoActive CurcuminProduct Name: NanoActive CurcuminOther Names: NanoActive turmeric extractAppearance: yellow, viscous and transparent liquidTest Method: HPLCCAS NO.: 458-37-7S...

Basic information of Capecitabine 154361-50-9

Name

Capecitabine

Alias

5'-DEOXY-5-FLUOROCYTISINE;5'-DEOXY-5-FLUORO-N-[(PENTYLOXY)CARBONYL]CYTIDINE;CAPECITABINE;RO-9-1978;pentyl [1-(3,4-dihydroxy-5-methyl-oxolan-2-yl)-5-fluoro-2-oxo-pyrimidin-4-yl]aminoformate;XELODA;Cpecitabine;5Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine, Ro-9-1978, Xeloda

CAS NO.

154361-50-9

Molecular Formula

C15H22FN3O6

Molecular Weight

359.35

Quality Standard

USP34

Package Size

1kg/bag,25kg/drum or per your requests

Use of Capecitabine 154361-50-9

  • Noval oral fluoride pyrimidine drug.
  • Anticancer drug, mainly used in non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.

COA of Capecitabine 154361-50-9

Items

Specifications

Results

Apperance

White or off-white crystalline powder

White crystalline powder

Identification

The spectrum of the sample corresponds to that of RS

Meets the requirements


The retention time of the major peak of the test solution corresponds to that of the RS

Meets the requirements

Specific Rotation

+96.0°~+100.0°

+98.1°

Water

≤0.3%

0.01%

Heavy Metals

≤20ppm

<20ppm

(as Pb)

Residue on ignition

≤0.1%

0.02%

Assay

98.0%~102.0%

99.70%



MORE_DETAIL Capecitabine 154361-50-9

Basic information of Capecitabine 154361-50-9

Name

Capecitabine

Alias

5'-DEOXY-5-FLUOROCYTISINE;5'-DEOXY-5-FLUORO-N-[(PENTYLOXY)CARBONYL]CYTIDINE;CAPECITABINE;RO-9-1978;pentyl [1-(3,4-dihydroxy-5-methyl-oxolan-2-yl)-5-fluoro-2-oxo-pyrimidin-4-yl]aminoformate;XELODA;Cpecitabine;5Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine, Ro-9-1978, Xeloda

CAS NO.

154361-50-9

Molecular Formula

C15H22FN3O6

Molecular Weight

359.35

Quality Standard

USP34

Package Size

1kg/bag,25kg/drum or per your requests

Use of Capecitabine 154361-50-9

  • Noval oral fluoride pyrimidine drug.
  • Anticancer drug, mainly used in non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.

COA of Capecitabine 154361-50-9

Items

Specifications

Results

Apperance

White or off-white crystalline powder

White crystalline powder

Identification

The spectrum of the sample corresponds to that of RS

Meets the requirements


The retention time of the major peak of the test solution corresponds to that of the RS

Meets the requirements

Specific Rotation

+96.0°~+100.0°

+98.1°

Water

≤0.3%

0.01%

Heavy Metals

≤20ppm

<20ppm

(as Pb)

Residue on ignition

≤0.1%

0.02%

Assay

98.0%~102.0%

99.70%


Related Articles
Leave a Message Email Us

we will contact you within 24 hours.

  • TEL:+86-0592-5854962
  • FAX:+86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Floor 16, Huicheng Business Center, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//